Abstract: Randomized controlled trials play an important role in how internet companies predict the impact of policy decisions, marketing campaigns, and product changes. Heterogeneity in treatment effects refers to the fact that, in such 'digital experiments', different units (people, devices, products) respond differently to the applied treatment. This article presents a fast and scalable Bayesian nonparametric analysis of heterogeneity and its measurement in relation to observable covariates. The analysis leads to a novel estimator of heterogeneity that is based around the distribution of covariates pooled across treatment groups. Results are provided to assess commonly used schemes for variance reduction, and we argue that such schemes will only be useful in estimation of average treatment effects if the sources of heterogeneity are known in advance or can be learned across multiple experiments. We also describe how, without any prior knowledge, one can mine experiment data to discover patterns of heterogeneity and communicate these results in sparse low dimensional summaries. Throughout, the work is illustrated with a detailed example experiment involving 21 million unique users of eBay.com.
Introduction
The internet is host to a massive amount of experimentation. Big online companies, and many small ones (e.g., using tools such as Google's site-optimizer), are constantly experimenting with changes to the 'user' experience. The treatments applied can involve changes to choice of the advertisements a user sees, the flow of information (e.g., in Facebook's newsfeed or in customer service), the algorithms used in product promotion (e.g., recommender engines, search ranking), the pricing scheme and market design, or any aspect of website look and function. eBay is constantly experimenting with these and other parts of the user experience, with the goal of making it easier for buyers and sellers of specific items to find each other. Fisher (1925) formalized randomized controlled trials as a technique for evaluation of causal treatment effects. His applications were focused in the field of agriculture, where the goal was to estimate the effects caused by interventions, such as choice of variety of barley and amount of fertilizer, on outcome variables such as crop yields per acre. He knew that the apparent effects of these interventions could be biased by differences, across the experimental units (plots of land), along other dimensions such as soil fertility and moisture content. To defeat such potential confounding factors at the time the data-gathering activity was planned, he systematized the then-haphazard field of experimental design by introducing the idea of randomizing experimental units to the various combinations of the treatment factors.
Ninety years later, randomized controlled trials remain the gold standard for causal inference. Among technology companies, the framework is referred to as 'A/B testing' for the random assignment of control (option A) and treatment (option B) to users.
1 Randomization (often along users, but potentially also on product, auction, or other dimensions) allows the firms to interpret estimated effects as caused by treatment decisions. However, despite sharing a foundation in treatment randomization, today's digital (i.e., internet) experiments differ from
Fisher's agricultural, and most experimentation of the 20th century, in two important ways.
a. The sample sizes are enormous. For example, our illustrative experiment has a sample size of over 21 million unique users. For a major internet commerce website this represents a fraction of US monthly traffic.
b. The effect sizes are tiny. The illustrative example in this article, where treatment involves increasing the size of product images, has response standard deviation around 1000 times larger than the estimated treatment effect. These effect sizes are now smaller than ever, since after years of experimentation most big influences have been found.
Moreover, as we will detail in Section 3.1, the response of interest (some transaction, such as user clicks or money spent) tends to be distributed with a majority spike at zero, an extremely long tail, residual variance that is correlated with available covariates, and other features that defy summarization through a standard parametric probability model.
Our analysis is purpose-built for digital experiments that exhibit these features. With respect to a, and accounting for the inapplicability of standard parametric models, we propose in Section 4 a fast and scalable nonparametric Bayesian inference framework that uses observed support (our 21 million users) as an approximation to population support for the data generating process. With respect to b, the work focuses on careful quantification of the variance of effect estimates. This is applied to assess commonly used schemes for variance reduction as well as to guide the search for heterogeneity in treatment effects.
Heterogeneous Treatment Effects
Imagine a single binary treatment, so that your site's visitors have been randomly assigned to either the control (standard experience) or treatment (some altered experience) version of the website. Useȳ d to denote the average response for group d, with d = c for control and d = t for treatment. Thenȳ t −ȳ c is a good estimator for the average treatment effect (ATE) -indeed, we will show that it is hard to do much better in the setting of digital experiments.
Such average effects are of interest to technology firms for obvious reasons; for example, if response y is related to your revenue then the ATE can be used to predict aggregate revenue gain after treatment. But the treatment effect for any individual user -the difference between how they would have responded under treatment rather than control -may be quite different from this average. This variability is referred to as the heterogeneity of treatment effects, and it seems self-evident that it exists: different experimental units (people, products, or devices) will each have unique responses to treatment. Suppose further that for each user response, y i , in either control or treatment, i ∈ c or i ∈ t respectively, there are available some preexperiment attributes, x i , which serve as potential covariates with y i . For example, if y i is during-experiment user spend, then x i might include details of pre-experiment spend (e.g., segmented by product category) and other activity by user i on our website. Then x i can potentially be used to index heterogeneity: we can try to model expected treatment effects as a function of the available covariates.
This article will investigate such models for heterogeneous treatment effects (HTE). Arguing through a nonparametric Bayesian framework, we contribute results in two areas.
Variance reduction: If you know in advance which elements of x affect y in a linear model, then you can use the model as the basis for lower variance estimate of the average treatment effect. Unfortunately the variance reduction is big only if the sample size is small, the heterogeneity is large and the linear model is correct -in digital experiments these conditions are unlikely. A more striking result: if you don't know which x to use or how it influences the response (in a single experiment), attempting to learn this from the data will not reduce variance.
In our framework, model uncertainty negates any gains from such 'regression adjustment'.
Mining heterogeneity: Without prior knowledge about the data generating process, except that treatment was randomized, we can mine experimental data to discover patterns of heterogeneity. Moreover, we present a decision-theoretic technique for sparse summarization of the high-dimensional nonparametric posterior distribution, producing a manageable set of inputs for decision making. However, the search for HTE requires a stomach for false discovery. In the setting of digital experiments, where sample sizes are just large enough to obtain statistical significance for the ATE, evidence of heterogeneity around this average will tend to be weak.
Outline
The next section defines our notation and summarizes the main results. Section 3 then introduces an experiment at eBay that will be referenced throughout in illustration. Section 4 details our nonparametric Bayesian framework, while Section 5 provides techniques for exact posterior sampling as well as first-order approximations to the posterior mean and variance. We then work through two application areas: regression-adjusted estimation for the ATE in Section 6 and mining of the full posterior for heterogeneity in Section 7. In each case, the methods and ideas will be illustrated on our eBay experiment. We close with a short discussion.
Notation and Summary
For each experimental unit i, to which we refer as a 'user' in analogy to our illustrative example, there is a response y i (e.g., amount of merchandise bought per week), a binary treatment
, and a
is always the intercept term).
2
There are n c users in control, n t in treatment, and n = (n c + n t ) total users. The n d × (p + 1)
designs for each of control and treatment groups are X c and X t , respectively, and these are accompanied by response vectors y c and y t . Stacked design and response are X =
Xc
Xt and y = [ yc yt ], so that i = 1 . . . n c are in control and i = n c + 1 . . . n are treated.
Bayesian nonparametric analysis and HTE estimators
Our approach to nonparametric inference has two main steps: we find a target statistic that is relevant to HTE regardless of the true data generating process (DGP), and we derive a posterior distribution for that statistic from a nonparametric Bayesian model for the DGP.
Our nonparametric model follows from classic work by Ferguson (1973) and more recent ideas in Chamberlain and Imbens (2003) . As detailed in Section 4, it describes the data through a multinomial probability function on possible {x, d, y} points. We apply a limiting non-informative prior, which implies using the observed data as our approximation for the population support. This provides a posterior over possible DGPs.
In targeting treatment effects, we adopt a potential outcomes framework and treat our data as partially observed. Each full data point would be x, υ(c), υ(t), with υ(d) the potential outcome either with or without treatment. In the sample, only one of these potential outcomes is actually observed. We then define the target of interest as a vector γ that satisfies, for a single realized DGP from the posterior, the moment condition E [x(υ(t) − υ(c) − x γ)] = 0.
A posterior distribution for γ is induced by our posterior over the DGP.
At the posterior mean DGP, the moment condition is satisfied bŷ
This is similar to a usual difference of OLS projections, as described in the 'interaction adjustment' of Section 2.3. The distinction is that (1) is projecting through a pooled estimate of the covariate variance, X X/n, instead of group-specific covariances. This makes intuitive sense: in a randomized control trial we know that the covariates were all drawn from the same distribution. The posterior variance for a first-order Taylor approximation to γ is supplied in closed form, following steps similar to those in Lancaster (2003) and Poirier (2011) . It is also simple (but more computationally expensive) to sample from the posterior for γ through use of the Bayesian bootstrap (Rubin, 1981) .
Average treatment effects
Based upon (1), a point estimate for the ATE isx γ, wherex is the full-sample covariate mean vector. This turns out to be exactly equal to the ATE estimator that ignores covariates:
More fundamentally, we show that analogous equivalence holds for any posterior-sampled DGP. That is, if µ is the DGP mean for x ,then µ γ will be equal to the difference of marginal posterior means for treatment and control response. Thus, there will be no change in the variance of the ATE whether or not you condition on the covariates. This occurs because we have mand no prior assumptions about the relationship between these covariates and the response.
This result provides some perspective on the recent controversy as to whether or not one should use covariates to adjust estimates of the ATE after a randomized controlled trial. Freedman (2008 a,b) provided an influential critique, arguing that the assumption of randomization is much weaker than those required for unbiasedness of OLS within each treatment group, and that regression adjustment can bias the treatment effect estimate. Lin (2013 ) (clarified in Lin, 2014 responds by showing that if your regression adjustment includes all treatment-covariate interactions (as those considered in the current article do), then Freedman's worries are re-solved and the average difference between OLS projected treatment effects gives an efficient and asymptotically unbiased estimate for the ATE, even in the presence of nonlinearity and model misspecification. The group of authors in Berk et al. (2013) and Pitkin et al. (2013) consider regression adjustment under random X (instead of the fixed designs of Lin and Freedman) and conclude that covariate adjustment will usually not hurt estimation, but it is seldom worth the effort in reduction of ATE variance. Our perspective is thus a step further than that of these last authors: under our modest modeling assumptions, ATE estimation is unchanged by the introduction of covariates.
Comparison to interaction adjustment
The above discussion of covariate adjustment to ATE estimates presumes that you do not have available the true parametric regression model. As an alternative, we also consider a setting where a linear model can be assumed for the relationship between x and y within each treatment
we can target directly this mean within each treatment group using the usual least-squares projections. Treatment effect heterogeneity is then defined through γ = (β t − β t ), which at posterior mean DGP is equal tô
This is a standard estimator of heterogeneity as advocated in, e.g., Lin (2013) or Berk et al. (2013) . Sinceγ could be re-written as OLS coefficients for an interaction between d and x in joint treatment/control sample regression
we refer to γ as the interaction-adjusted treatment effect. Working from our same nonparametric Bayesian viewpoint (i.e. making no new assumptions and still treating x as random), Section 6.2 details an approximate variance for the interaction-adjusted ATE (say, iATE)
where
is the OLS regression R 2 for each treatment group. Thus if one assumes linearity, so that the difference in OLS projections is the basis of heterogeneity, then you should see a small variance reduction from targeting the iATE rather than the ATE. This reduction will increase with the explanatory power of covariates (typically tiny for us) and decrease with the sample size (typically enormous).
One way that linearity holds trivially is if x i represents observation membership in each of a small set of mutually exclusive strata. In such a scenario, regression adjustment using (3) is referred to as post-stratification. The paper by Miratrix et al. (2013) for digital experiments with weak signals and massive samples, the gains will be small.
Mining for heterogeneity and sparse summarization
Despite the ATE being unaffected when we incorporate sources for heterogeneity, these sources do exist and they can be large. Indeed, our nonparametric strategy makes it possible to quickly summarize, for massive datasets, the posterior on treatment effect regression with a large number of covariates. From this perspective, it is a feature of our approach that we can explore heterogeneity without any change to the (unbiased) average effect.
The posterior distribution over γ describes p possible directions of heterogeneity. We have variable levels of uncertainty in each direction, and due to multicollinearity in X they are highly correlated with each other. A final contribution of this paper is to provide a technique for pulling out the few directions that look most promising for exploration, yielding results in dimensions low enough that they can be usefully communicated.
One rigorous way to construct this sparse summarization is to pose it as a decision, and then to minimize the posterior expectation for an appropriate loss function. Say δ is our 'decided' vector of heterogeneity. We want it to be mostly zero, so j δ j = 0 is part of the loss. We also want to summarize Xγ, so the loss includes distance between this and Xδ. Specifically, we will minimize the posterior expectation for
where penalty λ > 0 is the 'cost of complexity'. This resembles a L 0 penalized regression problem, and is related to the 'decoupled shrinkage and selection' procedure of Hahn and Carvalho (2014) . Specific to our case, we are focused on loss against a functional of the posterior rather than on the response. Also, notice the posterior variance for each projection appearing in the denominator of our squared loss. This discounts distance between the sparse rule and observations about which we have little information, and we demonstrate that it gives much more stable and useful answers than summaries based upon raw squared-error loss.
The fact that we are not necessarily seeking causal sources of heterogeneity makes our summarization task easier. Just finding user groups that tend to respond differently to stimuli is useful in itself; questions of causation can be deferred until later (or for ever). Certainly, since we will be working with sample sizes only large enough to detect the average effect, finding conclusive evidence for specific directions of heterogeneity will likely require further testing.
An illustrative example from eBay
The experiment that we provide to illustrate our ideas was run from March 21 to May 4 of 2012.
21 million users of the US eBay website were part of the experiment, randomly assigned 2/3 in treatment and 1/3 in control. 4 The treatment of interest was a change in image size for the items in a user's 'my eBay' page -a dashboard that keeps track of items the user has been interested in, has bid on or has inquired about. In particular, the pictures are increased from 96 pixels in control to 140 pixels for the treated. The experiment is typical of a 'product' experiment at eBay, where we are exploring user response to small changes on the website.
GMB and internet transaction data
At eBay, where buyers and sellers transact sales and purchases of items listed on the website, an important outcome variable is Gross Merchandise Volume Bought (GMB) over the life of the experiment. This variable is measured from the buyer's point of view and keeps track of the total US$ amount a buyer spends during the experiment.
We will target effects directly on the scale of y =$ GMB (or $ per week). Within eBay this is often converted to lift -GMB effect size over the control group average GMB -but significance calculation and uncertainty quantification occurs on the raw dollar scale. This response is typical of internet transaction data, in that it has
• a majority at zero, since most users do not make a transaction during the experiment;
• an extremely long right tail. For example, the maximum response value in this experiment is around $12 million GMB during the 5 week experiment;such as
• spikes of density at, e.g., psychological price thresholds $0.99, $100; and
• a variance that is correlated with both the treatment and sources of treatment heterogeneity. For our experiment, sd(y t ) = $5765 is much higher than sd(y c ) = $4849.
Such target response makes it difficult to devise believable parametric regression models.
This is the reason we rely upon nonparametric inference. An alternative would have been to attempt to explicitly model the heterogeneity through multi-stage models for, say, p(y > 0)
and E[log y | y > 0]. This is the approach advocated in Duan et al. (1983) , a classic study of demand for medical care that compares between 'heteroskedastic ANCOVA' and multi-stage parametric regression modeling. We avoid these approaches here for two reasons. First, such models remain implausible (e.g., due to density spikes and non-constant variance). Second, untransformed revenue is the business-relevant response. Randomized trials are performed by business analysts because they are interested in precise estimation of causal effects. To be useful in decision making, such effects need to be measured on the raw US$ scale upon which eBay makes money 5 In recognition of possible over-influence from extremely large y values, eBay performs sensitivity analysis that considers capped (Winsorized) GMB -with values larger than, say, $2500 per week replaced with this cap -along side the raw response analysis. 
shown for a range of caps on GMB -values that replace GMB larger than that threshold in our analysis.
Analysis without covariates
Before moving to include covariates, we consider a simple analysis of the average treatment effect based upon the difference between treatment and control group means. This is the standard analysis for A/B experiments at technology companies.
In our experiment, the estimated treatment effect on uncapped GMB isȳ t −ȳ c = $6. The corresponding standard error is se = 2.39 via a common formula for difference of means in the presence of heteroskedasticity,
This corresponds to a $1.20 per week effect, with se = 0.48, and a p-value of 0.008 for the two-sided hypothesis test of whether or not the treatment has any effect on the response. Thus we would conclude, with high statistical significance, that there is a positive effect on GMB due to increasing the image size. Figure 1 illustrates this result, along with the equivalent analysis for GMB that has been capped at a number of thresholds. The treatment lift is clearly sensitive to cap size, but we see that significance holds for a range of large cap values.
Covariate design
Our covariate design X, representing potential sources of heterogeneity, is built from metrics of user behavior tracked before the beginning of the experiment. Most metrics are aggregated over the four weeks prior to the start of the experiment, but we also include longer-term information in a three-dimensional indicator for whether the user made any purchases in the past month/quarter/year. Almost all of the variables are originally continuous and non-negative.
The user behavior metrics tracked include
• transaction information such as GMB and number of bought items (BI), sold items (SI), or GMB per bought item (GMB/BI; treated as zero when BI is zero); and
• activity information such as counts for site-session visits, page or item views, and actions such as bidding on an item (bids) or asking a seller a question (asq).
All of these variables are tracked in aggregate, as well as broken out by product category (e.g., collectibles, fashion, or 'unknown') and market platform (e.g., auction or fixed price).
This gives around 100 total raw variables. Our design is then constructed by expanding each into indicators for whether the variable is greater than or equal to each of its positive quintiles.
That is, there is a binary x ij element to indicate when the corresponding raw covariate is greater than 0 and when it is greater than or equal to the 20 th , 40 th , 60 th , and 80 th percentile of nonzero sample values for that variable. After collapsing across equal quintiles (e.g., many variables have up to 60 th percentile equal to one), this results in 391 design covariates. We also include the first 10 principal components of the correlation matrix for raw user behavior metrics, each scaled to have standard deviation of one, leading to a total of p = 401 covariates. The resulting 21 million by 402 dimensional design matrix, X, is very sparse with high multicollinearity.
The reader will notice that we're not considering an exhaustive, or even moderate, set of between-covariate interactions here. 6 This is due to practical limitations: with data of this size you will encounter integer overload just indexing the entries for all 2-3 way interactions.
Even with algorithms to fit such a model, or for stochastic search via, e.g., the random forests of our next section, this analysis would require more computational resources than we wish to allocate. The goal here is to try and identify a few large sources of heterogeneity; our nonparametric framework allows us to do so even in the presence of omitted interaction terms.
A first look at heterogeneity
Before moving to our full analysis framework, we'll explore heterogeneity by learning some flexible prediction rules on each of treatment and control groups and see how they differ. Figures 2 and 3 show fits for each of lasso regression (Tibshirani, 1996 , via the gamlr package in R) and random forest regression (Breiman, 2001 , via the randomForest package in R) of y d on X d within each group. In each case, the fitted functions clearly differ between treatment and control; for example, the completely different ordering of variable importance across random forests indicates fundamentally different regression tree fits. But, in the lasso fits at least, there are also striking similarities (e.g., influence of the last purchase indicators).
The inference question at hand is thus: are the functions really different? To decide, we need a model of uncertainty about each function and, unfortunately, we don't have a believable model. For example, the lasso fits presume linearity, which is surely false: even with only binary covariates, omitted interactions make this unrealistic. Flexible learners like random forests avoid linearity, but models for uncertainty about such functions will still be invalid for much internet transaction data. For example, Hill (2011) applies Bayesian additive regression trees (BART; Chipman et al., 2010 ) to obtain posterior distributions for tree-based regression in each treatment group. However, BART's posterior uses a homogeneous distribution for the additive error around its target surface, and is thus inappropriate for our assumed heteroskedastic errors. 7 We do not want to discount the usefulness of such semiparametric representationsit is often a good idea to condition on models that are known to be oversimplified. But our The top variables, by order of their contribution to drop in squared response error, for random forests fit to predict GMB within each of the treatment and control groups. To aid in understanding these (pre-experiment) variable labels, gmb is the GMB, gmv is the gross volume sold, SRP is a search results page, VI is a view item page, a2c is add-to-cart, bin is buy-it-now (fixed price sales), and purch denotes our indicators for the user's last purchase date.
Bayesian nonparametric alternative is able to contribute a complementary baseline analysis under minimal assumptions (and requiring far less computational effort).
As a final point, note that we could investigate which sources of heterogeneity are useful in predicting GMB by fitting a model for y regressed onto covariates X interacted with treatment indicator d (i.e., the model in (4)). But again this usefulness is based upon a model that assumes unrealistic linearity and homoskedastic error variance. Indeed, a lasso fit of the interaction model is inconclusive between approaches that should give roughly similar results if such assumptions held true. Information-theoretic penalty selection using the corrected AIC of Hurvich and Tsai (1989) , as applied in Taddy (2013) , yields several sources of heterogeneity including lastmonth and lastyear purchase indicators and the third principal component.
However, minimization of cross-validation error finds no effect of d or its interaction terms, not even the main effect that we know from Section 3.2 is significant.
Nonparametric Bayesian Analysis
We employ a Dirichlet-multinomial sampling model in nonparametric Bayesian (NPB) analysis. The approach dates back to Ferguson (1973) , Chamberlain and Imbens (2003) overview it in the context of econometric problems (including the estimation of treatment effects via instrumental variables), and Lancaster (2003) and Poirier (2011) provide detailed analysis of linear projections. Rubin (1981) proposed the Bayesian bootstrap as an algorithm for sampling from versions of the posterior implied by this strategy, and the algorithm has since become closely associated with this model. Use z i = {x i , d i , y i } to denote a covariate, treatment, and response triplet. The basic theory has that the data are drawn independently from a finite number L of possible values,
where ω l ≥ 0∀l and l ω l = 1. Thus the generating process for observation i samples l i from a multinomial with probability ω l i , and this indexes one of the L support points. Since L can be arbitrarily large, and all data are stored as discrete (up to machine tolerance), we have not yet made any restrictive assumptions beyond that of independence.
The conjugate prior for ω is a Dirichlet distribution, written
. We will parametrize the prior with a single concentration parameter
Suppose you have the observed sample
For convenience, say each observation is unique 8 and write l 1 . . . l n = 1 . . . n so that z i = ζ i and Z = [ζ 1 · · · ζ n ] . Then the posterior distribution for ω has ω i = a + 1 for i ≤ n and ω l = a for l > n, so that
This, in turn, defines our posterior for the data generating process through (8).
There are many possible strategies for specification of a and ζ l for l > n. 9 The noninformative prior that arises as a → 0 is a default with massive computational convenience: in this limit, ω l = 0 with probability one for l > n. 10 We apply this limiting prior throughout, such that our posterior for the data generating process is a multinomial draw from the observed data points, with a uniform Dir(1) distribution on the ω = [ω 1 . . . ω n ] sampling probabilities.
Inference without covariates
Rather than the posterior for the full data generating process, one is usually interested in some functional of this posterior. As a quick example, we can derive the exact posterior variance for
, the difference in marginal means analogous to our no-covariate anal-
this posterior variance is available as
This is a slight deflation of the usual sample variance formula, e.g., in (7).
8 Or rather, we allow ζ l = ζ k for l = k in the case of repeated values. 9 The unobserved ζ l act as data we imagine we might have seen, to smooth the posterior away from the data we have actually observed. See Poirier (2011) for discussion of how such values can be useful in application. 10 To see this, note that for l > n the posterior has E[ω l ] = 0 with variance var(ω l ) = lim a→0 a[n + a(L − 1)]/[(n + La) 2 (n + La + 1)] = 0. See also the simple demonstration in Chamberlain and Imbens (2003) .
Linear projection of heterogeneous treatment effects
For measuring HTE, the posterior functional of interest will provide a map between x and the treatment effect heterogeneity. Using the Neyman/Rubin language of potential outcomes, say
is the response associated with point l under treatment d. We define the treatment effect directions through the moment conditions
HTE coefficients γ are hence defined so that x γ is uncorrelated with the treatment effect
targets of inference are the covariance for x, and the covariances between x and υ(c) and υ(t).
Recall the finite-support generating process in (8). Under the limiting a → 0 prior, leading to p(ω l = 0) = 1 for l > n in the posterior, we overload notation to re-write the multinomial sampling weights as ω = [ω 1 . . . ω n ]. Define Ω = diag(ω) as the n × n weight operator. Then given a posterior realization for ω, the covariance for x is fully observed as
Uncertainty about this covariance matrix is engendered through the Dir(1) posterior on ω. 
This says that the unobserved values are missing completely at random, such that those observations contain no information about the conditional distribution of υ(d)|x. In practical terms, this implies that we can estimate the marginal response covariances based upon the observed
, and similarly for ω t , Ω t . From neutrality of the Dirichlet distribution to removal of dimensions (Connor and Mosimann, 1969) , we then have
Putting it all together, the posterior functional of interest is
and we call γ = [γ 0 , γ 1 , . . . , γ p ] the linear projection of treatment effect. 12 It is sometimes convenient to resolve (15) into treatment group-specific projections, in which case we write
Interaction adjustment for linear models
The derivation of the previous section places no assumptions on the DGP other than that of randomization for d. This is in contrast to many methods for regression adjustment, which posit linear model relationships between x and y within each treatment group (e.g., if x indicates membership in mutually exclusive strata, as in a post-stratification exercise).
Writing the assumption of linearity as E[υ(d)|x] = x β d , this implies that one could investigate HTE through the difference between regression functions, γ = β t − β t . We can target each linear mean using the population least-squares projections
At posterior mean DGP, which has ω = 1/n and ω d = 1/n d , this becomes the difference of OLS projections in treatment and control. This difference serves as the advocated estimator for HTE in Lin (2013), Berk et al. (2013) , and Pitkin et al. (2013) . As mentioned in the intro- 12 We're implicitly conditioning here on X ΩX being invertible. It is a characteristic of this article that we are considering p n designs and overdetermined systems. Thus invertibility holds with very high probability. However it clearly does not hold for all ω: e.g., having a single weight of one and the rest zero is not impossible. duction, it is also the OLS fit for an interaction between d and x in the joint treatment/control regression of (4). For this reason, and in reference to how related quantities have been described in the literature, we refer to (16) as the interaction-adjusted HTE.
Posterior inference
Given our interest in the DGP functionals γ and γ , we need to develop methods for summarizing their implied posterior. This section outlines a simple bootstrap posterior sampler, but also derives posterior mean and variance for first-order approximations to the functionals of interest. This latter approximate inference is useful for characterizing posterior variances, and is necessary for scaling for the datasets encountered during internet experimentation.
Sampling via the Bayesian bootstrap
Following Rubin (1981) , we can obtain a sample from the posterior on γ through a simple Bayesian bootstrap: for b = 1, . . . , B,
The same steps can be used to obtain posterior samples for the interaction-adjusted effects, γ , or any related functionals (e.g., ATE). We will use some small bootstraps in application to validate our approximate inference. However, with data on the scale encountered at eBay (e.g., our n = 21million users), even a single sum of squares X ΩX is computationally expensive (e.g., it may require partition of the sums into batches to be executed on multiple machines).
A first-order Taylor approximation
In every-day practice, it is preferable to work with analytic approximations to the posterior.
Here, we follow Lancaster (2003) and Poirier (2011) in replacing γ with a first-order Taylor series expansion around the solution atω = 1/n, the posterior mean for our multinomial sampling weights. The treatment effect atω iŝ
and we useγ as a point estimate for γ. When necessary, we pull out each treatment group
In expansion aroundγ, it is convenient to work with the constructive definition for the Dirichlet as a normalized vector of independent Gamma random variables. 13 In particular, for our posterior Dir(ω; 1), we can write the weights via independent θ = [θ 1 , . . . , θ n ] as
where Exp(1) denotes a standard exponential random variable. Moreover, ω c = θ c /|θ c | and ω t = θ t /|θ t | for the treatment and control subsets. Note that θ has posterior meanθ = 1 and γ remains the treatment effect projection at this point.
Write ∇u for the len(u) × n derivative of a vector u on θ. Then the first-order Taylor expansion around θ is
The (p + 1) × n gradient matrix, evaluated at mean θ =θ = 1, is derived in Appendix A as
where E = diag(e), and e = [e 1 . . . e n ] is the vector of 'treatment effect residuals'
Appendix B shows that e has a mean of zero and is orthogonal to all columns of X.
Posterior variance of the approximation
The approximation in (18) has posterior meanγ and exact posterior variance
since each θ i has an independent exponential posterior distribution, so var(θ) = I n . To facilitate computation, one can expand this variance as
with
via results from Appendix (B).
Posterior for interaction-adjusted HTE
We also derive a first-order Taylor approximation to the interaction-adjustedγ from (16), saỹ γ =γ + ∇γ θ=1 (θ − 1). Following the same steps as above, the approximation is centered onγ = (X t X t ) −1 X t y t − (X c X c ) −1 X c y c , and the gradient multiplier is
Since θ c ⊥ ⊥ θ t , the variance of this approximation is
where E d = diag(e d ) and e d = y d − X dβ d are the interaction model residuals for each treatment group. If we replace X with the design implied by the interaction regression in (4), X = [X d * X] where * denotes multiplication of every row x i by the corresponding
. This is exactly the Huber-White heteroskedastic consistent (HC) covariance estimator for OLS (White, 1980) , so that results here match the derivation from Lancaster (2003) and Poirier (2011) for nonparametric Bayesian analysis of OLS. Note that Lin (2013) also proposes this HC variance as the basis for standard errors on interaction-adjusted treatment effect estimates.
Average Treatment Effect
One common reason for modeling HTE is as a means to reduce variance in estimation of the average treatment effect. This section considers Bayesian nonparametric inference for ATEs based on either our treatment projections γ or the more common interaction adjustments γ .
Bayesian nonparametric ATE
Considering the nonparametric Bayesian setup of Section 4, and again using the notation of potential outcomes, the population average treatment effect is
Since υ i are only ever partially observed, this posterior functional cannot be targeted directly.
One alternative target would be the unadjusted average treatment effect (uATE) described in Section 4.1 and implicitly targeted in Section 3.2, the difference in treatment group means y t ω t − y c ω c . As already mentioned, this is by far the most commonly reported ATE. Or, you might wish to take advantage of our linear projected treatment effects, γ. Writing µ = Xω for the covariate mean, a Bayesian nonparametric ATE (bATE) is then µ γ. Given the moment condition from which we defined γ, the difference between unobserved pATE and this Bayesian bATE has expectation zero and is uncorrelated with (unpredictable from) x.
This turns out to be no choice at all: uATE and bATE are the same thing.
THEOREM 6.1. For any realization of ω such that X ΩX is invertible, µ γ = y t ω t − y c ω c .
Proof. Assume X has been centered to have column means of zero with respect to Ω, except for the first (intercept) column. It is straightforward to show that µ γ is unaffected by centering.
Then XΩ γ = µ γ = γ 0 , and X ΩX −1 is block-diagonal with its first block the scalar 1/|ω|.
Recalling that γ = (X ΩX) −1 (X t Ω t y t − X c Ω c y c ), this implies that γ 0 = ω t y t − ω c y c .
Thus, in our nonparametric Bayesian framework, you learn nothing new about the ATE by adding covariate information. This is due to the fact that γ is derived without any assumption about the relationship between x and y, and thus adds no prior information to the inference. A direct corollary of Theorem 6.1 is that our in-sample ATE estimate,x γ, is exactly equal to the sample average effect (ȳ t −ȳ c ). Morover, since the posterior functionals µ γ and y t ω t − y c ω c are actually the same quantity, they have the same posterior variance: σ 2 ATE from (10).
Comparison to interaction-adjusted ATE
In contrast, the interaction-adjusted ATE, say iATE = µ γ , will not be equal to the uATE. It is based on a representation of heterogeneity derived from a linear model in each treatment group, and tends to have lower posterior variance than the uATE (and hence than the bATE).
THEOREM 6.2. Conditional on µ =x, the ATE based on our Taylor approximation to the interaction-adjusted HTE has posterior variance
In (27) and in our proof, note that the first (intercept) element of eachx −x d is zero.
Proof. Consider the shifted OLS projectionsβ
, with variance that is the sum, across groups, of
and the formula for σ 2 ATE completes the result.
Thus the variance of interaction-adjusted iATE is the variance of unadjusted uATE minus a factor that increases with each treatment group OLS R 2 d and plus a factor that increases with the variance of these OLS projections (and thus decreases with each R 2 d ). Both factors decrease with sample size, in the latter case due to decreased OLS variance and because eachx d should move closer tox (since all x come from the same distribution). In practice, this says that interaction adjustment will only lead to large variance reduction if (a) there are large effects on y (high R 2 ) from the covariates and (b) the sample size is small.
A full approximation for the iATE variance is actually slightly larger than in (27), due to uncertainty about the covariate mean. Write µ γ = γ 0 + µ + γ + , where
dropping v 0 ). To fully account for uncertainty, we need to add the uncertainty corresponding to the non-intercept covariate average, µ + = X + ω, with variance
This uncertainty is combined with that around γ to get the full posterior variance
≈x Σγ x +γ + Σ µ + γ + + tr Σ µ + Σγ
The approximation of (30) results by replacing γ with its Taylor expansion and ignoring cov(µ, γ ), dependence between treatment effects and the covariate mean. 14 Such dependence will diminish very quickly with n, and our expression here has similarities to that in Pitkin et al. (2013) . The approximation (31) further ignores uncertainty about µ, and as mentioned in Section 5.4 its variance is based on the same HC covariance advocated in Lin (2013 
eBay illustration: average treatment effects
We will illustrate these results with a simple source of heterogeneity in our eBay experiments:
the three dummy variables indicating whether you've made at least one purchase in the past month, quarter, or year. 15 You can imagine the lastmonth indicator as representing likely frequent/heavy users, and a zero for lastyear indicates a new or lapsed user. Heterogeneity along these variables is of clear interest to decision makers, and investigation of effects specific to new users is already common. These variables are also among the first sources of heterogeneity selected, from the full candidate set of 400, in our sparse summary of Section 7.
In Section 3.2, we considered the effect of the treatment on all users. Another metric of interest is the treatment effect on the treated: of those who were known to have been exposed to a change, what was the average effect? In the context of the current experiment, that includes anyone who visited their my eBay page during the observation period. We consider estimation of these treatment effects using the cumulative data collected through each consecutive week of the 5 week experiment.
Posterior means and variances after each week are in Table 2 : Posterior sampling inference through 1-5 weeks. The means, percentages, and variances are taken from 1000 draws from the posterior after each week, via a Bayesian bootstrap.
centerγ and variance from (30). Note that in this simple example (this is not the case in the next section) the last-purchase information could instead be represented through three mutually exclusive strata, so that linearity holds trivially and the iATE is a valid quantity to consider.
Indeed, the iATE estimates here are exactly those advocated by Miratrix et al. (2013) . We see from the table that the uATE and iATE point estimates differ slightly, but that the discrepancy is within a fraction of the posterior standard deviation for each. Their variances are extremely close to each other, so there is little variance reduction benefit. The statistical significance for treatment effect actually decreases when you consider the iATE, because the point estimates have also moved closer to zero. In any case, the differences are small.
We also used the Bayesian bootstrap to sample 1000 points from the exact posteriors for γ, the uATE, and the iATE. The results are detailed in Table 2 : centers and uncertainty are very close to our approximate (and easy to compute) values from Table 1 7 Mining the full posterior for heterogenaity There are many settings in which the heterogeneity of treatment effects is interesting in and of itself. For example, new users are traditionally thought to react differently to website changes than existing users: if a change is 'good,' the new users will be happy, but any change, even something most see as an improvement, could create annoyance for an existing frequent user who needs to change habits as a result. Moreover, imagine a setting in which the aggregate negative response from existing users nearly balances the aggregate positive effect from new users. The ATE will be near zero, but that is not the information of relevance to a decision on whether or not to adopt the change: after a learning period we might expect older users to also like the improvement, making it an eventual gain for nearly everyone.
However, the complexity of a p-dimensional function for the treatment effect (as implied by γ) can be overwhelming. The full posterior, or the dense point estimateγ, might be of interest to a machine-learner building a system for automated website personalization. But from a management perspective, in which the experimental results are intended to guide highlevel decisions about strategy and design, findings in more than a handful of dimensions are hard to interpret and therefore unhelpful. We therefor wish to focus on a few key dimensions of customer-response heterogeneity for the purposes of decision-making, 16 and will advocate a decision-theoretic framework that encourages sparsity in the list of key heterogeneity factors.
A sparse decision rule
We address the problem via decision theory, viewed from a Bayesian perspective as detailed in, e.g., Berger (1985) . Treating the action space of the decision problem as consisting of vectors δ that serve as estimates of γ, a company-level loss function, implied by the above discussion, would penalize both discrepancy between γ and δ and the dimension of δ. For example, we could use L 2 loss on the distance between the true Xγ and its estimate Xδ, over the observed sample of users 17 . Moreover, if we wish to encourage tighter fit to those observations on which we have a more precise idea of the treatment effect, we could normalize each
16 Even if a given decision-maker has unlimited capacity for information complexity, it seems inadvisable to attempt to communicate and implement high-dimensional strategies in a large organization. 17 You could define the loss over any group of users, but this seems an obvious default.
by the corresponding posterior variance, var(x i γ). The implied loss function from this line of reasoning is then
where V is n × n diagonal with elements var(x i γ). 18 The w subscript here refers to the fact that the L 2 loss component is 'weighted' by each treatment effect variance, and this property is highlighted to contrast against the more common unweighted 'naïve' loss function
In each case, the total loss is some L 2 distance between true and estimated treatment effects plus a penalty, with magnitude λ > 0, on the number of nonzero elements in δ.
The posterior expected weighted loss is then, with P(γ) the posterior,
Removing constants and replacing var(γ) with the posterior variance of the Taylor expansion, (21), yields the posterior expected weighted loss objective
Similar arguments lead to the objective for posterior expected naïve loss,
In both cases, sparse decision-theoretic posterior summarization becomes a problem of L 0 penalized squared difference minimization. Notice that random vector γ has been replaced 18 Similar arguments could imply that we should instead be multiplying inside the L 2 norm by the full treatment effect covariance matrix, Xvar(γ)X . However such an n × n dense matrix would be impossibly large.
by statisticγ in the L 2 norm when moving from loss to expected loss. With the 'optimal' magnitude of the L 0 penalty, λ, likely unknown or undefined, we will minimize (35) over a path of interesting values. Hahn and Carvalho (2014) survey this type of sparse decision-theoretic posterior summary in the context of prediction loss and provide a specific 'decoupled shrinkage and selection'
(DSS) algorithm that targets minimization of L 0 penalized squared-error loss. Specific to our case, we are focused on loss against a functional of the posterior rather than on the response.
Also, variance weighting in R w is important: in our setting we have highly variable uncertainty about the treatment projections for different individuals, and this objective discounts distance between the sparse rule and observations about which we have little information. In the example of Section 7.3, R w gives more stable and useful answers than those based upon R n .
Gamma lasso approximation to L 0 penalized objective
The L 0 -penalized objective in (35) is nearly impossible to optimize in most settings. Instead, we replace the L 0 cost with something that leads to more tractable minimization. A common choice here is L 1 -penalized minimization, often referred to as the lasso (Tibshirani, 1996) , but it is possible to get closer to the L 0 ideal through use of diminishing-bias regularization, i.e., schemes that mimic penalty norms < 1.
Taddy (2013) provides an overview of diminishing bias from the perspective necessary here, which seeks to approximate L 0 -penalized optimization (rather than some assumed but unknown sparse 'truth'). Many of the possible diminishing-bias algorithms can be phrased -at least in their scalable, big data implementations -as weighted L 1 penalization, where the weights diminish with variable importance (signal strength). Taddy (2013) introduces the gamma lasso algorithm for a simple and fast adaptive re-weighted L 1 scheme. This algorithm provides weights that diminish as a function of |δ t j | along a path of decreasing λ t . The tuning parameter of the gamma lasso, γ > 0, governs how quickly bias diminishes. In particular, for large γ and large λ (i.e., at the simpler approximations) we can be confident that the gamma lasso solution is close to the optimal L 0 -penalized solution. See Taddy (2013) for a more complete survey of the relevant literature, more results on weighted L 1 approximation to L 0 penalized objectives, and additional algorithm details.
eBay illustration: high-dimensional and sparse heterogeneity
Finally, we consider the posterior distribution for the full 402-dimensional γ associated with our eBay experiment. Recall that this includes expansion, into positive quintile indicators, for each of 100 user attributes that were measured before the beginning of the experiment, along with the first 10 principal components of these raw attributes, and indicators for whether the user has made any purchases in the past month, quarter, or year. We will focus on the posterior for treatment effects on the 13 million treated users -those known to have visited their my eBay page during the five weeks of our experiment. Figure 7: Gamma lasso regularization paths for approximate minimization of the posterior expected loss in (35). The left plot shows the fit for the posterior corresponding to raw $ GMB response, while the right corresponds to GMB capped at $2500.
The plot in Figure 7 shows the path of decided sources for heterogenaity, δ, as a function of complexity cost, λ, from minimization of the variance-weighted posterior expected loss in (35).
As detailed in Section 7.2, these paths apply a gamma lasso algorithm to provide approximate solutions for the target L 0 penalized objective; the results here use the gamlr package for R.
19
The two panels of Figure 7 correspond to posteriors for response values y taken as both raw 19 We apply the default gamlr routine under the setting gamma=10.
GMB $ per week and capped at $2500 per week. Each point along the path presents a possible sparse summarization, depending upon one's tolerance for complexity. For example, focusing on the four factor solutions (plus intercept), the raw GMB HTE summary has coefficients intercept lastmonth lastyear PC3 asq_cnt>=2 2.03 2.63 -1.60 2.74 -0.40
This includes two of our familiar last-purchase indicators, along with the third principal component and an indicator for whether the user has 'asked a seller a question' (asq) more than once in the pre-experiment month. For y capped at $2500/week, the 4-factor posterior HTE summary has coefficients intercept lastmonth lastyear PC3 VI_sess_count>=1 4.66
1.95 -4.71 2.23 -0.49
Thus the two last-purchase indicators, along with PC3, have summary inclusion that is stable to the capping. The effect on PC3 is especially significant: 'standardized' effect sizê γ PC3 /sd(γ PC3 ) is 250 for raw GMB and 630 for capped GMB. Investigation of the rotations behind PC3 reveal that it is big for buyers and sellers of 'unknown' items, those which were deemed uncategorizable within eBay's taxonomy (and perhaps those whose ease-of-viewing through larger images is most valued, since they defy easy description).
In comparison, minimization of the unweighted L 0 penalized loss in (36) yields less stable and less useful results. For example, the corresponding sparse summaries for raw GMB yield very large (absolute value $10-100) coefficients on variables related to bought items by business and industry or sold items in electronics. Our guess is that the unweighted loss function is targeting extremely large values of x γ. Indeed, when applied to capped GMB, which should also remove some sensitivity to extreme values, the unweighted loss yields summaries starting with the same PC3 and lastmonth factors we find through the variance-weighted loss.
As a closing point of caution, we show in Figure 8 Figure 8: Histograms for standardized heterogeneous effects,γ j /sd(γ j ), in the posteriors for both raw and capped GMB. These plots exclude the (massively significant) effects for PC3, which is standardized at 250 (raw) and 630 (capped).
inevitably be mixed in with 'big noise', and we should expect false discovery when exploring the large effect estimates. Thus there is substantial heterogeneity, but finding it is likely even harder than the task for which the experiment (i.e., its sample size) was designed: finding average treatment effects. This should not discourage researchers from mining for heterogeneity;
however, such an exercise should be viewed as exploratory, perhaps inspiring product ideas that you can then test in future experiments.
Conclusion
This article provides a complete framework for understanding the measurement and use of heterogeneous treatment effects (HTE). We do not advocate this as the only approach to inference.
Following from our results in the previous section, the search for HTE in digital experiments is very much a 'needle in a haystack' problem -more akin to modern genetics, and genome-wide association studies, than to the agricultural experiments of Fisher's era. Thus it may well be useful for researchers to build more prior model structure into their search, even if such structure is more useful than true. We hope that our Bayesian nonparametric analysis can serve as a point of reference: if your results are quite different from ours, perhaps you may wish to investigate which assumptions are leading to the discrepancy.
As a closing point, we note that the classical Ferguson (1973) nonparametric setup, and especially the standard model of Chamberlain and Imbens (2003) that uses observed support to approximate population support, is a useful theoretical framework for Big data problems where sample n is larger than, say, the population of the Netherlands.
Appendices A Treatment effect gradient
Define S = X ΩX for the population gram matrix. Then
This simplifies considerably upon noting that
where ∂ω i /∂θ is the length-n vector with j th element 1 [i=j] /|θ| − θ j /|θ| 2 , and similarly for ∇vec(Ω d ) but with rows missing and columns zero for j / ∈ d. Thus, for example,
is the (p + 1) × n gradient matrix for the control group projection.
Finally, taking ∇γ = ∇β t − ∇β c and evaluating atθ = 1, where S = X X/n and β d =β d , we arrive at the expression in (19).
B Treatment effect residuals
To build intuition and aid later results, we look here at the treatment effect residuals. Use e c = [e 1 , . . . , e nc ] and e t = [e nc+1 , . . . , e n ] for the group-specific residuals.
PROPOSITION B.1. For our treatment projections i 1 e = 0
ii −X c e c = X t e t = X t X tβ c + X c X cβ t
iii X e = 0
Proof. For i, we useȳ t −ȳ t =x γ from Theorem 6.1. For ii, notice that
n n c X t y t − n n c X c y c .
Multiplying the first term by I = (X c X c + X t X t )(X X) −1 and collecting terms gives our result. Finally, iii is a direct consequence of ii.
